SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is experiencing a parabolic rally driven by a structural, AI-fueled super-cycle in NAND flash memory demand that is expected to persist through 2027. While bulls point to persistent chip shortages and massive institutional inflows as evidence of a multi-year growth trend, community discourse is heavily divided between those treating the stock as an "infinite money" opportunity and bears warning of a potential rug-pull due to extreme overvaluation and historical cyclical volatility.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing heightened market attention following high-profile executive orders prioritizing quantum technology, with the community actively tracking the company's strategic alignment with government objectives. Investors are intensely debating the stock's volatility and its potential for a significant breakout as they weigh short-term technical pressure against long-term growth prospects in the quantum sensing and computing sector.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is experiencing extreme volatility and intense community debate as investors react to its post-IPO price correction, with many questioning whether the stock is a long-term innovation play or an overvalued liquidity trap for retail. Discourse is currently dominated by conflicting views on the company's aggressive expansion into AI and infrastructure versus skepticism surrounding its massive debt and the potential for further selling pressure once insider lock-up periods expire.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as a major beneficiary of the AI infrastructure expansion, with surging demand for high-bandwidth memory (HBM) and a new strategic partnership with Anthropic driving significant buying momentum. While the community is actively debating the stock's valuation and potential for an 'AI bubble' collapse, bullish sentiment remains strong as investors anticipate significant earnings growth and further structural re-rating following the upcoming earnings report.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF is seeing strong bullish momentum as investors pile into the memory sector, driven by aggressive demand for high-bandwidth memory (HBM) and storage solutions in the burgeoning AI infrastructure cycle. The community is actively discussing the stock as a 'blind buy' for long-term exposure to this structural bottleneck, with many pointing to the increasing convergence of industry leaders like Micron, SK Hynix, and Samsung into a re-rated AI-supercycle narrative.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is facing increased volatility as investors weigh lingering concerns over potential interest rate hikes against recent geopolitical developments in the Middle East. Market participants are actively debating whether the current pullback is a healthy rotation out of overheated tech and AI stocks or a precursor to a broader liquidity-driven correction.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing a sharp sell-off as investors react to concerns over European government contract losses and broader weakness in the software sector, leading many to debate whether the stock is hitting a technical breakdown or a long-term accumulation opportunity. Community discussion remains highly polarized, with vocal bears pointing to valuation concerns and high-profile short-seller interest, while long-term bulls argue that the company's core defense contracts and AI platform fundamentals remain intact despite the heavy volatility.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is seeing heightened investor activity as the market anticipates key maintenance study data later this year, with ongoing debates centering on the company's potential to remain independent versus being a prime acquisition target. Community sentiment remains polarized between long-term holders betting on the disruptive potential of VK2735 and skeptics wary of dilution risks and the management's strategic pace in a rapidly evolving obesity market.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing extreme selling pressure, hitting new 52-week lows as community sentiment splits between retail traders calling for a "buy the dip" bounce and frustrated long-term holders lamenting a lack of positive catalysts. The conversation is heavily dominated by debates over the stock's valuation, disappointment regarding management's failure to execute promised share buybacks, and concerns that the company's streaming growth is losing momentum against modern digital entertainment platforms.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is surging as the nations dominant chipmakers, Samsung and SK Hynix, capitalize on an explosive demand for high-bandwidth memory driven by global AI infrastructure expansion. The community is focused on the massive valuation gap between these tech-heavy Korean firms and their US counterparts, fueling debates on whether this rally represents a long-term structural re-rating or an overextended trade vulnerable to volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ARS Pharmaceuticals Q1 Earnings Call Highlights

ARS Pharmaceuticals Q1 Earnings Call Highlights...

ARS Pharmaceuticals Q1 2026 Earnings Call Transcript

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of -15.09% and +2.01%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

ARS Pharmaceuticals Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) to release first quarter earnings on May 15 before opening bell. Analysts expect a loss of 54 cents per share.read more...

Eton Pharmaceuticals, Inc. (ETON) Misses Q1 Earnings Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -50.00% and +8.48%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Merck KGaA (MKKGY) Surpasses Q1 Earnings and Revenue Estimates

Merck KGaA (MKKGY) delivered earnings and revenue surprises of +31.11% and +3.89%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Cronos Group (CRON) Q1 Earnings Meet Estimates

Cronos (CRON) delivered earnings and revenue surprises of 0.00% and +6.94%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat Estimates

Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of +23.94% and +7.01%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: ARS Pharmaceuticals, Inc. (SPRY) Q1 Earnings Expected to Decline

ARS Pharmaceuticals, Inc. (SPRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ARS Pharmaceuticals (SPRY) Projected to Post Quarterly Earnings on Wednesday

ARS Pharmaceuticals (NASDAQ:SPRY) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 13. (View Earnings Report at...

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$9.98
Prev Close	$9.65
Open	$9.82
Dividend Yield	0.00%
50-Day Moving Average	$8.60
Beta	1.33
Avg. Volume	1.93M
PE Ratio	-4.99

52-Week High	$18.90
52-Week Low	$6.66
Market Capitalization	$958.28M
EPS (Annual)	-$1.74
Price to Book	16.16
Revenue Per Employee	$517,042.95

Feed

News

Sentiment

Earnings

Fundamentals

Info

SPRYARS Pharmaceuticals Inc

Latest SPRY News